£54.67

Cambridge University Press Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006

Price data last checked 76 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£55 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 15 days • 15 data points (No recent data available)

Historical
Generating forecast...
£69.55 £53.18 £56.75 £60.32 £63.90 £67.47 £71.04 08 April 2026 11 April 2026 15 April 2026 18 April 2026 22 April 2026

Price Distribution

Price distribution over 15 days • 3 price levels

Days at Price
Current Price
4 days · current 9 days 2 days 0 2 5 7 9 £55 £68 £70 Days at Price

Price Analysis

Most common price: £68 (9 days, 60.0%)

Price range: £55 - £70

Price levels: 3 different prices over 15 days

Description

Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. Review "Insights provided in this text concerning clinical trials will allow prescribers to feel more confident regarding the medications they prescribe and the quality research on which clinical efficacy has been established. The research is presented in a detailed yet concise and very readable format. The text provides valuable information regarding neuropsychopharmacology research and treatment. It is a well-written and concise read for scientist-practicioners who want an understanding of the clinical trials that support multiple uses of many commonly prescribed agents. It is a must-read for neurologists, psychiatrists, prescribing psychologists, nurse practicioners, and neuroscientists, particularly those interested in clinical issues. Readers who have an interest in the neurobiology of psychiatric issues may be especially interested in this text. This text would be an excellent complement to pharmacology courses because it provides valuable information concerning the drug development process. In addition, this collection of works may facilitate flexible and creative prescribing practices by evaluating agents in populations and for symptoms other than those for which they were initially developed." Book Description An essential update of clinical trials in the management of neurological and neuropsychiatric disorders. About the Author Jeffrey L. Cummings, MD, is currently Director of both the Deane F. Johnson Center for Neurotherapeutics at UCLA, and the UCLA Alzheimer's Disease Center. He holds the Augustus Rose Professor of Neurology chair, was the Shrinavasan Lecturer in 2004 and the Henderson Lecturer in 2005.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Clinical Trials in Neurology: 138 (Neuromethods, 138)
97% match

Clinical Trials in Neurology: 138 (Neuromethods, 138)

Humana

£143.83 08 Mar 2026
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 2, 2007
97% match

Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 2, 2007

Cambridge University Press

£49.36 21 Apr 2026
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 2, 2007
96% match

Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 2, 2007

Cambridge University Press

£65.20 06 Mar 2026
Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)
96% match

Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)

Springer

£108.78 14 Apr 2026
Autophagy Dysfunction in Alzheimer's Disease and Dementia
96% match

Autophagy Dysfunction in Alzheimer's Disease and Dementia

Academic Press

£98.99 24 Apr 2026
Academic Press Cancer Immunotherapy - Volume 164 Book
96% match

Academic Press Cancer Immunotherapy - Volume 164 Book

Academic Press

£124.97 27 Apr 2026
Clinical Trials in Neurology: 138 (Neuromethods, 138)
96% match

Clinical Trials in Neurology: 138 (Neuromethods, 138)

Humana

£111.73 16 Jun 2026
Clinical Trials in Neurology
96% match

Clinical Trials in Neurology

Springer

£179.50 12 Jun 2026
Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
96% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Academic Press

£114.49 10 Mar 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
96% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.44 05 Apr 2026
Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)
96% match

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Humana

£150.58 30 Mar 2026
Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)
96% match

Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)

Humana

£99.99 25 Apr 2026
CNS Neuroprotection: 155 (Handbook of Experimental Pharmacology, 155)
96% match

CNS Neuroprotection: 155 (Handbook of Experimental Pharmacology, 155)

Springer

£249.99 04 Jul 2026
Humana Neurotherapeutics: Emerging Strategies Book
96% match

Humana Neurotherapeutics: Emerging Strategies Book

Humana

£113.76 26 Apr 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
96% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£204.76 14 Jun 2026
Movement Disorders Curricula
96% match

Movement Disorders Curricula

Springer

£257.02 04 Jul 2026
Neuropsychological Neurology: The Neurocognitive Impairments of Neurological Disorders
96% match

Neuropsychological Neurology: The Neurocognitive Impairments of Neurological Disorders

Cambridge University Press

£33.12 13 Jun 2026
Advances in Neuroscience, Neuropsychiatry, and Neurology
96% match

Advances in Neuroscience, Neuropsychiatry, and Neurology

£352.00 14 Apr 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume IV: Molecular Genetic and Genomic Markers: 04
96% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume IV: Molecular Genetic and Genomic Markers: 04

Springer

£105.90 24 Jun 2026
Academic Press Molecular Biology of Neurodegenerative Diseases
96% match

Academic Press Molecular Biology of Neurodegenerative Diseases

Academic Press

£131.99 27 Apr 2026
Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107
96% match

Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107

Academic Press

£96.25 09 Mar 2026
Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)
96% match

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Elsevier

£220.00 14 Jun 2026
Physician's Field Guide to Neuropsychology: Collaboration through Case Example
96% match

Physician's Field Guide to Neuropsychology: Collaboration through Case Example

Springer

£136.66 10 Jun 2026
Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)
96% match

Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)

Academic Press

£79.99 11 Mar 2026